Thomas Egebøl
København, Region Hovedstaden, Danmark
2 t følgere
500+ forbindelser
Om
Transformation Executive with international consulting background
I make things…
Aktivitet
2 t følgere
-
Thomas Egebøl delte detteThomas Egebøl delte detteThis new paper reveals exactly why we need to investigate vaccines for their effect on OVERALL health (all-cause mortality and hospitalizations) - and not just their protective effects against the vaccine infection and commonly known side effects. It is a comprehensive study of the Chinese Sinovac COVID-19 vaccine. It shows that the vaccine has profound effects on a number of parameters including: * HbA1c, an indicator of elevated blood glucose and diabetes, was increased. * Indicators of renal dysfunction were increased. * Several coagulation factors were affected. Noteworthy, there were dramatic alterations in gene expression of almost all immune cells after vaccination. The direction indicates that there could be compromised immune function: "these data suggested that after vaccination, at least by day 28, other than generation of neutralizing antibodies, people’s immune systems, including those of lymphocytes and monocytes, were perhaps in a more vulnerable state" - and the authors also conclude that "Our study postulates that it is imperative to consider the potential long-term impact of vaccination to certain medical conditions or to general human health". Unfortunately, since the current system for approving vaccines does not take into account that the vaccines could affect the immune system more broadly (i.e. that they have non-specific effects #NSEvac), vaccines are not studied for their effect on the risk of other infections before being approved. Hence, we have no data to refute the possibility that these new vaccines could affect the risk of other infections negatively. There are examples of vaccines, which protected against the vaccine disease, but nonetheless did not have the anticipated beneficial effect on overall health - or even worsened overall health - due to negative non-specific effects on the risk of other diseases (e.g. Aaby et al, Lancet 2003). Thus, there is an urgent need to revise the current system for approving vaccines: It should be imperative to document that a vaccine reduces all-cause mortality and hospitalization risk (or at least does not lead to increases) before a vaccine can be given full approval. https://lnkd.in/d9g2WhnhComprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines - Cell DiscoveryComprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines - Cell Discovery
-
Thomas Egebøl delte detteFor en fokuseret KAM er der en mulighed for at levere en virkelig høj vækstThomas Egebøl delte detteDet bliver spændende... https://lnkd.in/erwYRss
-
Thomas Egebøl delte detteEzenta er blevet købt af den europæiske og børsnoterede it-sikkerhedsvirksomhed Nixu Corporation. Ezenta er eksperter i teknologibaseret it-sikkerhed og giver dermed Nixu en markant position på det danske marked for it-sikkerhed. Se mere på: https://lnkd.in/gu79ZEh
-
Thomas Egebøl reagerede på detteThomas Egebøl reagerede på detteDen sikkerhedspolitiske situation er yderligere forværret. Rusland er blevet mere risikovillig og eskalerer sin hybridkrig mod NATO, ikke mindst med stadig mere omfattende sabotagehandlinger i europæiske lande. I dag offentliggør FE en ny vurdering af truslen fra Rusland. Trusselsvurderingen bygger på FE’s efterretninger og har følgende hovedkonklusioner: • FE vurderer, at Rusland i de kommende måneder yderligere eskalerer sin hybridkrig mod NATO og Vesten. • Der er en lav, men stigende risiko for, at Rusland vil gennemføre begrænsede militære angreb mod et NATO-land – selvom krigen i Ukraine fortsætter. • Selv om vi anser det for usandsynligt, at Rusland vil forsøge en egentlig invasion af et NATO-land, kan vi ikke længere udelukke det. 🇩🇰 Læs hele trusselsvurderingen her -> https://direc.to/p3q3 🇬🇧 Read the DDIS’ threat assessment of Russia -> https://direc.to/p3q9 Rusland er under stort pres, både økonomisk og militært. Der er ikke udsigt til en afslutning på krigen inden for det kommende halve år. Det er derfor sandsynligt, at Rusland vil tage skridt i løbet af de kommende måneder for at vende udviklingen i Ukraine-krigen. FE vurderer, at Rusland i de kommende måneder vil intensivere sin hybridkrig mod Vesten og NATO yderligere. Det kan eksempelvis omfatte destruktive cyberangreb med alvorlige konsekvenser for samfundsvigtige funktioner og sabotageangreb med høj risiko for tilskadekomne. Rusland er allerede i højere grad begyndt at gå direkte efter den vestlige militære støtte til Ukraine enten på våbenfabrikker i de europæiske lande eller under transport mod Ukraine. Der er samtidig en lav, men stigende risiko for, at Rusland i løbet af de kommende måneder vil tage eskalationen et skridt videre ved at iværksætte et begrænset militært angreb mod et eller flere NATO-lande. Det kan være enkeltstående angreb med langtrækkende våben mod infrastruktur i et NATO-land, der grænser op til Rusland. Der kan også være tale om en begrænset indsættelse af militære styrker i NATO-lande, der grænser op til Rusland. Formålet med militære angreb vil være at flytte europæiske ressourcer væk fra støtten til Ukraine og underminere troværdigheden af NATO's artikel 5. Risikoen for, at Rusland beslutter at udføre militære angreb mod et eller flere NATO-lande er forøget, indtil de europæiske landes aktuelle oprustning er blevet omsat til reel kampkraft. Rusland ser i de kommende år en form for mulighedsvindue, hvor Putin kan nå den konklusion, at det er værd at forsøge drastisk at ændre den sikkerhedspolitiske orden i Europa ved at udføre militære angreb mod et eller flere NATO-lande, også selvom det er risikabelt. FE ser fortsat ingen tegn på, at Rusland vil iværksætte en egentlig militær invasion med regulære styrker af et eller flere NATO-lande. Det er usandsynligt, at Rusland vil forsøge en egentlig invasion af et NATO-land, men vi kan ikke længere udelukke det.
-
Thomas Egebøl syntes godt om detteThomas Egebøl syntes godt om detteAv, av, av … nu bliver Scott Bessent kørt fuldstændig over. Han har her til eftermiddag annonceret nye obligationstilbagekøb – basalt set det trick, han forsøgte for en måned siden. Når man køber obligationer, så er formålet at presse obligationsprisen OP og dermed obligationsrenten ned. Det lykkedes bare ikke – de amerikanske obligationsrenter fortsætter op. Og vi er netop nu hoppet over det niveau for den 30-årige statsobligationsrente, som han midlertidigt fik presset renterne under for en måned siden. Investorerne tror ikke på Bessent. Han kan ikke presse renterne længere ned. Investorerne ved, at han ingen penge har. Han skal grundlæggende sælge obligationer for at kunne købe obligationer. Og ja, så har det ingen effekt. Så er der kun to andre udveje. Enten får han Federal Reserve til at købe obligationer for nytrykte dollars – og det afviste Fed-chef Kevin Warsh reelt for 14 dage siden, da han sagde, at der fortsat var arbejde at gøre i forhold til at få inflationen ned. Med andre ord: "Sorry, vi kan ikke købe obligationer, vi vil nemlig gerne have renten op for at få inflationen ned." Og ja, så giver det kun én mulighed for Bessent: at stramme finanspolitikken. Højere skatter og afgifter og lavere offentlige udgifter. Er der nogen, der tror på det forud for midtvejsvalget? Næppe … så nu må renterne yderligere i vejret. Og ja, jeg har sagt det før – det ligner mere og mere en regulær statsgældskrise i USA. Hvis du vil høre mere, så har vi talt om præcis de emner i de seneste tre afsnit af Makropuls. I det seneste afsnit, der er offentliggjort i dag, stiller vi skarpt på den renteforhøjelse, som ECB givetvis kommer til at levere i morgen. Se link i kommentarerne.
-
Thomas Egebøl syntes godt om detteThomas Egebøl syntes godt om detteSouth Africa has gone back to The Hague. - On 25 August, Pretoria put a new dossier before the International Court of Justice. The message is simple: Israel has not obeyed the Court’s own orders on Gaza, and South Africa wants the judges to see it in writing. DIRCO made that public on 28 August. This is not a new case. It is the same case South Africa opened in December 2023 under the Genocide Convention — the same legal door many African states walked through after 1948, when the world promised “never again” and meant it for everybody, not just some people. The Court has already spoken three times. January, March and May 2024. Binding orders. Prevent genocidal acts. Let aid through. Preserve evidence. Open the door to UN investigators. The judges said Palestinians in Gaza face a real and imminent risk of irreparable harm. Those orders are still in force. The final judgment is years away. That is exactly why the orders exist: so people are not erased while lawyers argue. South Africa says Israel has not complied. It points to continued bombardment, mass death and injury, displacement, hunger for water, medicine and basic supplies, detention, and a Gaza that keeps shrinking around the people still alive inside it. Pretoria’s own figures, as of August 2026: at least 73,407 killed, 174,335 injured since 7 October 2023 — more than one in ten of Gaza’s population — and tens of thousands living with amputations, brain and spinal injuries. Those numbers come from South Africa’s filing. Israel rejects the genocide charge and says it is fighting Hamas. The Court has not given its final word. The orders, however, were not optional. This is also not Pretoria’s first follow-up. Letters and public dossiers already went to the UN Security Council in May 2024, February 2025 and September 2025. Same demand: enforce the Court’s orders. The Council has not delivered. So South Africa is back at the Court, using Article 11 of the judges’ own internal rules, feeding evidence to the committee that watches compliance. That is how a state that takes international law seriously behaves when the powerful treat The Hague as a suggestion box. For Africa this matters beyond Gaza. If a UN court can issue binding measures and the world looks away, then the law is only law when it is convenient. South Africa is saying the opposite: the Convention applies in Palestine the same way it must apply on this continent. Self-defence is not a blank cheque. That is Pretoria’s line, and it has not moved. The big case crawls on. South Africa’s next full written reply is due November 2027. Israel’s rejoinder, May 2029. Years. Meanwhile the dossier on the table is about what is happening now. Africa filed. The judges have the papers. The question left is whether the rest of the world will treat an African-led case as the law or as noise.
-
Thomas Egebøl syntes godt om detteThomas Egebøl syntes godt om detteHvordan giver man noget videre, som man har brugt næsten 30 år på at bygge op – uden at give slip på det, der betyder mest? Det spørgsmål har Logos Consults stiftere Peter Frøbert og Flemming Mortensen, skullet forholde sig til i forbindelse med salget af virksomheden. Nyheden har skabt stor interesse. Vejle Amts Folkeblad har derfor talt med Peter om beslutningen og de overvejelser, der ligger bag. For Logos Consult er mere end et navn og en virksomhed. Det er vores arbejdsplads, vores dygtige medarbejdere, vores kultur og de mange kunderelationer, vi har opbygget gennem årene. Derfor har det været afgørende at finde en ny ejer, som respekterer det, Logos Consult er bygget på, og samtidig kan være med til at udvikle virksomheden videre. Peter og Flemming fortsætter begge i Logos Consult A/S. Det samme gør vores ledelse og medarbejdere. Vores kunder vil fortsat møde de mennesker og få den rådgivning, de kender – nu med flere kompetencer og større kapacitet i ryggen. Tak til Vejle Amts Folkeblad for en god og personlig artikel. Læs artiklen her: https://lnkd.in/ef_iEcNh
-
Thomas Egebøl syntes godt om detteThomas Egebøl syntes godt om detteCelebrating 30 years of Heidrick & Struggles in Denmark. It was a real pleasure to mark this milestone together with so many clients, colleagues, business leaders, and friends who have been part of our journey over the years. We were especially delighted to welcome our Global CEO, Tom Monahan and our Regional Leader, Jenni Hibbert to Copenhagen to celebrate with us. A big thank you to everyone who joined us at Skuespilhuset and helped make the day so special. We are grateful for the relationships we have built over the past 30 years and for the trust our clients continue to place in us. #Leadership #ExecutiveSearch #LeadershipAdvisory #Denmark
-
Thomas Egebøl syntes godt om detteThomas Egebøl syntes godt om detteEfter mange år i en meget stor virksomhed begyndte jeg for nogle år siden at arbejde mere med nogle meget små virksomheder. Noget af det første, der slog mig, var tempoet. I en startup eller scale-up kan man diskutere et problem mandag, træffe beslutningen tirsdag og have ændringen implementeret fredag. I en stor virksomhed kan man i samme periode nogle gange nå at nedsætte en arbejdsgruppe. Men der er selvfølgelig en grund til, at større virksomheder har processer. Når organisationen vokser, kan man ikke basere det hele på korte beslutningsveje og personlig viden. Og her har scale-ups en særlig udfordring. Mange vokser organisk. Det, der fungerede med 10 eller 20 medarbejdere, fungerer måske også med 40. Lige indtil det ikke gør. Pludselig ligger for mange beslutninger hos founder, vigtig viden hos enkelte personer, og de uformelle processer, der tidligere var en styrke, bliver en flaskehals. Nogle gange opdager man det først rigtigt, når scale-up'en møder corporate-verdenen – fx i en kapitalrunde, med en større investor eller i et strategisk partnerskab. Så støder to virkeligheder sammen. Scale-up'en er vant til at tale sammen, beslutte og komme videre. Corporate skal måske omkring legal, compliance, procurement, risk og flere ledelseslag. Fra den ene side ligner det bureaukrati. Fra den anden kan scale-up'en ligne improvisation. Begge kan have en pointe. Problemet opstår, når man tror, at den anden bare gør tingene forkert. Derfor er der efter min mening to opgaver: Scale-up'en skal huske, at organisationen også skal skaleres – ikke kun omsætningen. Og når de to verdener mødes, skal man tidligt afklare mandat, beslutningsveje, nødvendige processer og forventninger til tempo. Scale-up'en skal ikke blive corporate. Og corporate skal ikke lege startup. Kunsten er at få startup'ens tempo og nysgerrighed til at fungere sammen med den store virksomheds disciplin og risikoforståelse. Måske handler det ikke om at fjerne forskellene. Men om at opdage dem, før de bliver et problem.
-
Thomas Egebøl reagerede på detteThomas Egebøl reagerede på detteIt is now confirmed that russia was behind the attack on the Leipzig Airport 4th of August. What we miss is the response from NATO, EU and Germany. Remember when NATO said they will defend every inch of NATO territory? Let us see if Leipzig Airport is a part of NATO... #Leipzig #NATO #EU #russia #hybridwarfare #airport #sabotage #drones
Erfaring
-
Egebøl consulting
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Uddannelse
-
INSEAD
-
–
The Executive Board Programme INSEAD is a board training program, centered around the complexity of the future’s board work, good corporate governance and the competences it takes to play a valuable leading role as a board member.
-
-
–
-
-
–
-
-
–
-
-
–
Testresultat
-
GMAT
Resultat: 690 (top 4%)
Anbefalinger, som du har modtaget
18 personer har anbefalet Thomas
Tilmeld dig for at se hvemAndre lignende profiler
Se flere indlæg
-
Mary Gao
Novo chairman steps down after clash with shareholder board: Facing declining sales of its blockbuster weight-loss drugs, Novo Nordisk on Tuesday announced a leadership shakeup orchestrated by its biggest shareholder. Chairman Helge Lund and six board members will leave the company. Former CEO Lars Rebien Sørensen will return as chairman after overseeing the Novo Nordisk Foundation, a nonprofit that owns a controlling stake in the drugmaker and pushed the changes. Novo shares have fallen more than 50% this year, leading to a CEO change in July and layoffs in September as rival Eli Lilly gains market share.
1 Kommentar -
Luca Pignato
Congratulations to our client VIVATIS Holding AG on the sale of SENNA Nahrungsmittel GmbH & Co KG to Orkla Food Ingredients AS. With annual sales of around €1.43 billion (2025), Vivatis Holding AG is one of the largest purely Austrian companies in the food and beverage industry. Senna is a leading Austrian producer of margarine, specialty fats, oils as well as sauces and dressings supplying the foodservice, artisan bakery and industrial segments across Europe. Orkla Food Ingredients supplies ingredients to a broad range of customers in the bakery, ice cream and plant-based markets, and has a leading position in Europe and a platform for growth in the USA. Livingstone is proud to have supported Vivatis Holding AG as exclusive financial advisor in this transaction.
7 Kommentarer -
Priyanshi Rajput
🌍 India–Finland Relations Reach a New Milestone India and Finland have recently elevated their bilateral ties to a “Strategic Partnership in Digitalisation and Sustainability.” The announcement came during the visit of Finnish President Alexander Stubb to India, where he held discussions with Prime Minister Narendra Modi in New Delhi. Both countries signed multiple agreements aimed at strengthening cooperation in key sectors such as: • Digitalisation & emerging technologies • Clean energy and sustainability • Artificial Intelligence, quantum computing & 6G • Trade, innovation and research collaboration A renewed environmental cooperation agreement will also promote joint efforts in pollution control, waste management, climate action and sustainable resource management. This partnership highlights how innovation, sustainability and technology diplomacy are becoming central to global collaborations. Why this Matters • Strengthens India–Europe relations • Boosts innovation and tech partnerships • Creates opportunities for students, startups and researchers • Promotes sustainable development and climate action Global partnerships like this show how collaboration drives progress in the modern world. #IndiaFinlandRelations #GlobalPartnership #Digitalisation #Sustainability #TechnologyCollaboration #InternationalRelations #Geopolitics #LinkedInLearning #CurrentAffairs #Innovation
1 Kommentar -
Mats Lind
RETENTION WEEKLY NEWS, Svenska företag har en enorm potential i Indien men många misslyckas, varför? Läs och reflektera, Mats L Why Foreign Companies Fail in India: 5 Costly Mistakes and Lessons for Future Investors. KEY FINDINGS - Between 2014 and 2021, more than 2,783 foreign firms exited India - Over 40 percent of foreign companies fail within five years of market entry - Foreign companies in emerging markets often fail not due to weak products, but because of inadequate preparation Foreign companies often fail in India due to five recurring mistakes: choosing the wrong entry structure, misjudging regulatory complexity, misreading consumer behavior, adopting poor market models, and weak talent management. https://lnkd.in/dRMwPzTn